Twelve European Countries Recently Reported 94 Mpox Cases

Since the start of the outbreak in May 2022,  the Monkeypox virus (MPXV) clade I and clade II have been detected circulating in multiple countries, including those in Europe.

As of July 28, 2025, there have been 24,995 confirmed cases of mpox (MPX) reported from 29 EU/EEA countries.

Over the last seven weeks, the European CDC reported 12 EU/EEA countries reported 94 mpox cases. 

These countires are led by Germany (56), followed by Spain (14), France (6), Netherlands (5), Belgium (3), Czechia (2), Portugal (2), Sweden (2), Ireland (1), Italy (1), Romania (1) and Slovenia (1).

The ECDC stated on August 1, 2025, that the overall risk remains low for most European populations. However, as summer travel and Pride season are ongoing, transmission of the MPXV could increase, and it is essential to raise awareness of this vaccine-preventable disease.

To the west of Europe, the United Kingdom has reported 14 mpox cases this year in England. As of the end of June 2025, most of these mpox cases have reported direct or indirect links to travel to countries where mpox clade Ib is circulating.

As of August 5, 2025, an effective and safe mpox vaccine (JYNNEOS®, MVA-BN®, IMVAMUNE®) is available throughout Europe and in the United States.